Search research articles
Contact Us
Filters
Showing results (191-200 of 261) with videos related to
Page
of 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2022
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
John D Martin, Ryan M Lanning, Vikash P Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2026
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Cancers
|
October 14, 2023
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Nature Clinical Practice. Oncology
|
April 28, 2007
Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer
Christopher G Willett, Dan G Duda, Emmanuelle di Tomaso, et al.
Cancer Medicine
|
August 25, 2019
Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma
Eudocia Q Lee, Alona Muzikansky, Dan G Duda, et al.
Future Oncology (London, England)
|
March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, et al.
Journal of Neuro-Oncology
|
November 18, 2016
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
Jayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, et al.
The Oncologist
|
May 12, 2021
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
Sara M Tolaney, David R Ziehr, Hao Guo, et al.
Clinical and Translational Radiation Oncology
|
February 9, 2026
Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review
Lara Caglayan, Oliver Blanck, Judit Boda-Heggemann, et al.
Journal of the National Cancer Institute
|
November 9, 2015
Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
Vasileios Askoxylakis, Gino B Ferraro, David P Kodack, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 261) with videos related to
Sort By:
Page
of 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2022
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
John D Martin, Ryan M Lanning, Vikash P Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2026
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Cancers
|
October 14, 2023
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Nature Clinical Practice. Oncology
|
April 28, 2007
Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer
Christopher G Willett, Dan G Duda, Emmanuelle di Tomaso, et al.
Cancer Medicine
|
August 25, 2019
Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma
Eudocia Q Lee, Alona Muzikansky, Dan G Duda, et al.
Future Oncology (London, England)
|
March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, et al.
Journal of Neuro-Oncology
|
November 18, 2016
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
Jayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, et al.
The Oncologist
|
May 12, 2021
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
Sara M Tolaney, David R Ziehr, Hao Guo, et al.
Clinical and Translational Radiation Oncology
|
February 9, 2026
Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review
Lara Caglayan, Oliver Blanck, Judit Boda-Heggemann, et al.
Journal of the National Cancer Institute
|
November 9, 2015
Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
Vasileios Askoxylakis, Gino B Ferraro, David P Kodack, et al.
Page
of 27